StockData
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc. (COYA) KPIs and segments

COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.02+0.02 (+0.67%)

Close on Nov 17, 2026Market cap $70.84MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Coya Therapeutics's business

Coming soon

This tab will track the numbers specific to Coya Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?